kelatorphan has been researched along with rb 101 in 3 studies
| Studies (kelatorphan) | Trials (kelatorphan) | Recent Studies (post-2010) (kelatorphan) | Studies (rb 101) | Trials (rb 101) | Recent Studies (post-2010) (rb 101) |
|---|---|---|---|---|---|
| 58 | 0 | 1 | 57 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Durieux, C; Fournié-Zaluski, MC; Roques, BP; Ruiz-Gayo, M | 1 |
| Boudinot, E; Denavit-Saubié, M; Fournié-Zaluski, M; Foutz, AS; Morin-Surun, M; Roques, BP | 1 |
| Bansal, N; Fonseca, A; Gillis, J; Gulati, A; Horine, SV; Kuppalli, S; Mendelson, A; Southerland, WA | 1 |
1 review(s) available for kelatorphan and rb 101
| Article | Year |
|---|---|
Dual Enkephalinase Inhibitors and Their Role in Chronic Pain Management.
Topics: CD13 Antigens; Chronic Pain; Dipeptides; Disulfides; Enkephalins; Enzyme Inhibitors; Humans; Neprilysin; Phenylalanine; Propionates; Propylamines | 2021 |
2 other study(ies) available for kelatorphan and rb 101
| Article | Year |
|---|---|
Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Topics: Analgesics; Analgesics, Opioid; Animals; Cholecystokinin; Dipeptides; Disulfides; Dose-Response Relationship, Drug; Enkephalins; Male; Mice; Narcotic Antagonists; Peptide Fragments; Phenylalanine; Prodrugs; Receptors, Cholecystokinin; Receptors, Opioid | 1992 |
Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.
Topics: Analgesics; Animals; Cats; Dipeptides; Disulfides; Enkephalins; Enzyme Inhibitors; Mice; Naloxone; Narcotic Antagonists; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Respiration | 2001 |